Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Erik Oleson to Reward

This is a "connection" page, showing publications Erik Oleson has written about Reward.

 
Connection Strength
 
 
 
2.466
 
  1. Everett TJ, Gomez DM, Hamilton LR, Oleson EB. Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance. Prog Neuropsychopharmacol Biol Psychiatry. 2021 01 10; 104:110031.
    View in: PubMed
    Score: 0.608
  2. Pultorak KJ, Schelp SA, Isaacs DP, Krzystyniak G, Oleson EB. A Transient Dopamine Signal Represents Avoidance Value and Causally Influences the Demand to Avoid. eNeuro. 2018 Mar-Apr; 5(2).
    View in: PubMed
    Score: 0.524
  3. Oleson EB, Cheer JF. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb Perspect Med. 2012 Aug 01; 2(8).
    View in: PubMed
    Score: 0.351
  4. Oleson EB, Cheer JF. Paradoxical effects of the endocannabinoid uptake inhibitor VDM11 on accumbal neural encoding of reward predictive cues. Synapse. 2012 Nov; 66(11):984-8.
    View in: PubMed
    Score: 0.350
  5. Peters KZ, Oleson EB, Cheer JF. A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction. Cold Spring Harb Perspect Med. 2021 01 04; 11(1).
    View in: PubMed
    Score: 0.157
  6. Oleson EB, Roberts JB. The power of price compels you: Behavioral economic insights into dopamine-based valuation of rewarding and aversively motivated behavior. Brain Res. 2019 06 15; 1713:32-41.
    View in: PubMed
    Score: 0.136
  7. Wang B, You ZB, Oleson EB, Cheer JF, Myal S, Wise RA. Conditioned contribution of peripheral cocaine actions to cocaine reward and cocaine-seeking. Neuropsychopharmacology. 2013 Aug; 38(9):1763-9.
    View in: PubMed
    Score: 0.092
  8. Oleson EB, Ferris MJ, Espa?a RA, Harp J, Jones SR. Effects of the histamine H1 receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward. Eur J Pharmacol. 2012 May 15; 683(1-3):161-5.
    View in: PubMed
    Score: 0.085
  9. Oleson EB, Beckert MV, Morra JT, Lansink CS, Cachope R, Abdullah RA, Loriaux AL, Schetters D, Pattij T, Roitman MF, Lichtman AH, Cheer JF. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron. 2012 Jan 26; 73(2):360-73.
    View in: PubMed
    Score: 0.085
  10. Wenzel JM, Oleson EB, Gove WN, Cole AB, Gyawali U, Dantrassy HM, Bluett RJ, Dryanovski DI, Stuber GD, Deisseroth K, Mathur BN, Patel S, Lupica CR, Cheer JF. Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain. Curr Biol. 2018 05 07; 28(9):1392-1404.e5.
    View in: PubMed
    Score: 0.033
  11. Hernandez G, Oleson EB, Gentry RN, Abbas Z, Bernstein DL, Arvanitogiannis A, Cheer JF. Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates. Biol Psychiatry. 2014 Mar 15; 75(6):487-98.
    View in: PubMed
    Score: 0.024
  12. Loewinger GC, Oleson EB, Cheer JF. Using dopamine research to generate rational cannabinoid drug policy. Drug Test Anal. 2013 Jan; 5(1):22-6.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)